info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Asia Pacific Lignocaine Market Size

ID: MRFR//3139-HCR | 85 Pages | Author: Rahul Gotadki| November 2024

The lignocaine market is substantially motivated by its significant use in medical and dental procedures. As a neighborhood anesthetic, lignocaine is extensively used to numb precise areas of the body in the course of surgeries, dental work, and diverse medical interventions, contributing to its excessive demand. The growing range of surgical processes globally is a key motive force for the lignocaine market. Surgeons typically use lignocaine to obtain local anesthesia, making it a vital element in loads of surgical specialties, starting from dermatology to orthopedics. Lignocaine's pivotal function in dentistry, mainly for neighborhood anesthesia throughout dental processes, substantially influences the market. The increasing area of dentistry and the rising cognizance of oral health contributes to the sustained demand for lignocaine in dental practices.
Lignocaine is broadly utilized in pain management, each as a standalone agent and in combination with different medicines. Its effectiveness in assuaging aches, specifically in minor surgical strategies and dermatological remedies, impacts its market increase in the broader context of ache management. Lignocaine's use as an emergency medicinal drug, including in cardiac arrhythmia control, contributes to its market demand. Its rapid onset of action and efficacy in crucial situations make it a valuable device for healthcare professionals in emergency settings. Lignocaine is typically used in topical formulations for numbing the skin floor. Topical applications, which include creams and gels, have been discovered to be used in dermatology for minor skin processes, in addition to increasing the market for lignocaine. The upward thrust in continual illnesses, necessitating various scientific interventions, contributes to the lignocaine market's growth. Conditions, together with cardiovascular sicknesses and certain cancers, can also require strategies wherein local anesthesia with lignocaine is carried out.
Lignocaine's application in orthopedic procedures, together with joint injections or nearby nerve blocks, performs a role in market dynamics. Orthopedic surgeries and interventions often contain the use of lignocaine for powerful pain manipulation. The lignocaine market extends to veterinary medicine, in which it's been applied for local anesthesia in various animal approaches. The growing cognizance of animal health and veterinary care contributes to the demand for lignocaine within the veterinary region. The market is tormented by the presence of regularly occurring formulations of lignocaine. Generic competition can influence pricing dynamics, making fee-effective alternatives available to healthcare companies and impacting market proportions. Regulatory frameworks and compliance requirements set by health authorities impact the lignocaine market. Stringent rules ensure the safety and efficacy of clinical merchandise, affecting product approvals and market access. Collaborations among pharmaceutical businesses, research establishments, and healthcare providers contribute to improvements in lignocaine formulations. These partnerships power research funding and innovation in the market.

Covered Aspects:

Report Attribute/Metric Details
Growth Rate 5.90% (2022-2030)

Asia Pacific Lignocaine Market Overview 


The Asia Pacific Lignocaine Market is expected to reach USD 1,137.41 Million by 2030 at 5.90% CAGR during the forecast period 2022-2030. Lidocaine, also known as xylocaine or lignocaine, is a medication used in a spectrum of medical applications such as local anaesthetic, to treat ventricular tachycardia or arrhythmia, and to perform nerve blocks. Inhaled lidocaine is a cough suppressor that reduces cough reflex. Lidocaine’s mechanism of action is blocking sodium channels, thus preventing local neuron signal from reaching the brain. Lidocaine is an antiarrhythmic medication which reduces the contraction of heart.

Asia Pacific Lignocaine Market

Common side effects of lidocaine include sleepiness, muscle twitching, confusion, changes in vision, numbness, tingling sensation, vomiting, low blood pressure and an irregular heart rate. It is generally safe to use in pregnancy but patients with liver problems may require a smaller dose. Lidocaine is on the Asia Pacific Health Organization's List of Essential Medicines, and is inexpensive. Adverse effects of lidocaine are tremors, euphoria, hallucinations, bradycardia, arrhythmias, bronchospasm, dyspnea, etc.

 

The lidocaine sales are suffering from lignocaine market fragmentation, which has put pressure on the price margins. The generics have captured the major market share and the rise of counterfeited products has also restricted the market growth. The other market constrains are low price and adverse side effects of lidocaine use. Market development strategy has been constrained as lidocaine has been around market for many decades. Thus there is presence of huge production capacity which has also put pressure on prices. This has led to large players quitting the market. However, product development in the form of formulation development has been successful as exemplified by inhalation sprays. Moreover the high volume and low value nature of lidocaine has restricted the market to small players.

 

However, the lignocaine market is extremely stable and a player with efficient production will reflect stable revenues, the presence of large governmental contract market also needs to be tapped. Thus, production and distribution efficiency coupled with product development strategies is expected to be critical factors in the Asia Pacific lidocaine market.

 

Figure 1   Asia Pacific Lignocaine Market by Applications, 2016 (%)Asia Pacific Lignocaine Market-

Asia Pacific Lignocaine Market Segmentation


The Asia Pacific Lignocaine market has been segmented on the basis of application, formulation and end user.


Based on the application, the lignocaine market has been segmented as local anesthesia, anti-arrhythmic and others.


Based on the formulation, the lignocaine market has been segmented as injectable, topical, inhalation and others.


Based on the end user, the lignocaine market has been segmented as hospitals & clinics, academic and research, and others.


Asia Pacific Lignocaine Market Regional Analysis


The Asia Pacific region accounts for a significant lignocaine market share owing to large population and fast developing and expanding healthcare facilities. Additionally, the large unmet needs of populous countries such as China and India is resulting in greater growth of the Lignocaine market in the regions. The sluggish growth of the developed regions of world also has resulted in transfer of growth of the lignocaine market to the developing markets of Asia Pacific. The lidocaine market is expected to be led by countries such as China and India due to their large populations and large industrial base as compared to other Asia Pacific countries. However the nations of Vietnam, Cambodia, Myanmar, Indonesia etc. are witnessing faster growth as compared to other Asia Pacific countries.


The poorly developed countries are expected to be the fastest growing regions in the Asia Pacific. The larger unmet needs and the faster development of health facilities coupled with the cheaper and essential nature of the lidocaine is driving the market in these regions. The growing application of lidocaine for veterinary use is expected to drive the future market as these countries have large animal population.


Furthermore, concentration of the large low end and low tech companies in the developing countries of this region such as China and India is resulting in excess capacity which needs to be exploited. However the growth in this region can be constrained by the current political conditions, and poor healthcare development.


Key Players in the Asia Pacific Lignocaine Market


Some of the key players profiled in the report are:



  • Croma-Pharma GmbH

  • Cironpharma

  • Endo Pharmaceuticals

  • ESBA Laboratories 

  • Sigma-Aldrich 

  • Swati Spentose Pvt. Ltd. 

  • Sambria Pharmaceuticals

  • Pierrel S.p.A.

  • Galen US Inc.

  • Mahendra Chemicals 

  • Iwaki Seiyaku Co., Ltd.

  • Biotechnica Pharma Asia Pacific

  • Harman Finochem Limited

  • Endo International


Intended Audience



  • Asia Pacific Lignocaine treatment manufacturers & suppliers

  • Research and development (R&D) companies

  • Hospitals and clinics

  • Academic institutes and universities



Research Methodology Asia Pacific Lignocaine Market


Sources: Mayo Clinic, Healthline Media, MRFR Analysis


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.